Wang Anderson A

Show results for

Unknown (5272)
Proteomics (42)
Transcriptomics (31)
Genomics (24)
Metabolomics (22)
Genomic (2)
Other (2)

Organisms

Homo sapiens (71)
Mus musculus (14)
Saccharomyces cerevisiae (4)
Severe acute respiratory syndrome coronavirus 2 (1)
Plasmodium falciparum (1)

Organisms

Saccharomyces cerevisiae (4)
Homo sapiens (2)
gut metagenome (1)

Repository

pride (38)
biostudies-arrayexpress (32)
MetaboLights (22)
EGA (13)
ENA (8)
geo (4)
dbGaP (2)
MassIVE (2)
PanoramaPublic (2)

Tissue

Cell culture (8)
Permanent cell line cell (5)
Early embryonic cell (4)
HEK-293T cell (3)
Blood cell (2)
Epithelial cell (2)
Kidney (2)
Blood (1)
Brain (1)
Embryo (1)
Epithelium of pancreatic duct (1)
Esophagus (1)
Eye (1)
Fibroblast (1)
HeLa cell (1)
Heart (1)
Lung (1)
MCF-10A cell (1)
Malignant cell (1)
Mesothelium (1)
Ovary (1)
PanIN cell (1)
Pancreatic duct (1)
Pancreatic ductal adenocarcinoma cell (1)
Peritoneal cavity (1)
Sensory processing neuron (1)
Uterine endometrium (1)

Disease

Disease free (4)
Acute leukemia (2)
Cervix carcinoma (2)
Age related macular degeneration (1)
Barrett's esophagus (1)
Cardiovascular system disease (1)
Malaria (1)
Ovarian cancer (1)
Pancreatic ductal adenocarcinoma (1)
Peritoneal mesothelioma (1)
Sensory peripheral neuropathy (1)

Technology Type

Mass Spectrometry (38)
Mass spectrometry (21)
Affinity purification coupled with mass spectrometry proteomics (16)
Shotgun proteomics (14)
Bottom-up proteomics (8)
Data-dependent acquisition (4)
AB SOLiD 4 System, Illumina HiSeq 2500, Illumina HiSeq 2000, AB SOLiD System 3.0 (1)
Mass spectrometry assay (1)
Affinity proteomics (1)
Gel-based experiment (1)
SWATH MS (1)
Top-down proteomics (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (9)
Liquid Chromatography MS - negative - reverse phase (7)
Liquid Chromatography MS - positive - hilic (5)
Liquid Chromatography MS - negative - hilic (3)
LECO Pegasus 4D (2)
Liquid Chromatography MS - negative (2)
Liquid Chromatography MS - positive (2)
Illumina HiSeq 2500 (1)
Orbitrap Fusion Lumos (1)
Liquid Chromatography MS - (1)
Liquid Chromatography MS - alternating (1)
Liquid Chromatography MS - alternating - reverse phase - Exactive (Thermo Scientific) (1)
Liquid Chromatography MS - alternating – hilic (1)
Liquid Chromatography MS – negative - reverse phase (1)
MS Imaging - (1)
Q Exactive (1)

Publication Date

2023 (12)
2021 (7)
2016 (7)
2015 (7)
2020 (7)
2024 (7)
2022 (7)
2026 (6)
2014 (5)
2013 (5)
2012 (5)
2017 (4)
2019 (4)
2018 (4)
2010 (3)
2025 (3)
2011 (2)
2008 (2)
2009 (1)

CHEBI ID

CHEBI:16704 (12)
CHEBI:16737 (12)
CHEBI:17368 (12)
CHEBI:17568 (12)
CHEBI:17596 (12)
CHEBI:15891 (11)
CHEBI:17895 (11)
CHEBI:15727 (10)
CHEBI:16467 (10)
CHEBI:17203 (10)
CHEBI:17964 (10)
CHEBI:18019 (10)
CHEBI:28875 (10)
CHEBI:30746 (10)
CHEBI:15354 (9)
CHEBI:15756 (9)
CHEBI:16235 (9)
CHEBI:16335 (9)
CHEBI:16414 (9)
CHEBI:16643 (9)
CHEBI:16919 (9)
CHEBI:17154 (9)
CHEBI:17295 (9)
CHEBI:17351 (9)
CHEBI:17650 (9)
CHEBI:30769 (9)
CHEBI:116314 (8)
CHEBI:15971 (8)
CHEBI:16015 (8)
CHEBI:16027 (8)

Metabolite Name

Uracil (10)
Hypoxanthine (9)
Inosine (8)
Uric acid (8)
Adenosine (7)
L-Arginine (7)
L-Proline (7)
L-Tyrosine (7)
Xanthine (7)
Benzoic acid (6)
Choline (6)
Creatinine (6)
Guanine (6)
L-Isoleucine (6)
L-Lysine (6)
L-Methionine (6)
L-Phenylalanine (6)
Nicotinic acid (6)
Palmitic acid (6)
Uridine (6)
5'-Methylthioadenosine (5)
Carnosine (5)
Cholesterol (5)
Citric acid (5)
Indole (5)
L-Histidine (5)
L-Leucine (5)
L-Tryptophan (5)
L-Valine (5)
Mannitol (5)

First Public Date

2020 (4)
2025 (2)
2023 (1)
2014 (1)

Modification

15.994915 (4)
57.021464 (4)
71.037114 (3)

Study type

Transcription profiling by array (23)
Comparative genomic hybridization by array (2)
ChIP-seq (2)
RNA-seq of coding RNA (2)
RNAi profiling by array (1)
Methylation profiling by high throughput sequencing (1)
RNA-seq of non coding RNA (1)

Release Date

2021 (517)
2022 (475)
2023 (417)
2020 (417)
2025 (414)
2024 (405)
2018 (362)
2019 (338)
2016 (337)
2017 (326)
2015 (284)
2014 (224)
2013 (200)
2012 (140)
2011 (115)
2010 (99)
2009 (70)
2026 (57)
2008 (53)
2007 (23)
2006 (10)
2005 (7)
2004 (3)
2003 (3)
2002 (2)
2000 (2)
2001 (1)
1998 (1)
1996 (1)

Lab affiliation

Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA (4)
Experimental Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA (4)
Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA (3)
Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX (2)
Assistant Professor, Department of Chemistry, The ScrippsResearch Institute (1)
Biomolecular mass spectrometry and proteomics group, Utrecht University (1)
Cell Signalling and Proteomics Group, Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, EC1M6BQ, UK (1)
Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research and Department of Molecular and Translational Sciences, Monash University, Clayton, Victoria, Australia. (1)
Chair of Proteomics and Bioanalytics, Technical University of Munich, Bavaria, Germany (1)
Clinical & Health Sciences, University of South Australia, Adelaide, SA 5095, Australia. (1)
Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center (1)
Department of Molecular and Cellular Oncology, MD Anderson Cancer Center, Houston, TX USA (1)
Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center (1)
Department of Neurobiology, Harvard Medical School; Boston, USA. (1)
Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Alberta T2N 1N4 Canada Snyder Insitute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Alberta T2N 1N4 Canada (1)
Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia (1)
Experimental Radiation Oncology department, The University of Texas MD Anderson Cancer Center (1)
Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center (1)
Experimental Radiation Oncology, The University of Texas, MD Anderson Cancer Center (1)
Harvard Department of Stem Cell and Regenerative Biology Cambridge, MA 02138, USA (1)
Leukemia Department, MD Anderson Cancer Center, Houston, TX 77030 (1)
MD Anderson Cancer Center (1)
Novartis Institutes for Biomedical Research, 22 Windsor Street, Cambridge MA 02139, USA (1)
OmicVision Biosciences ApS (1)
Professor, Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX (1)
SULFAGING group; Leibniz Institute for Analytical Sciences - ISAS - eV. Dortmund, GERMANY (1)
The University of Texas MD Anderson Cancer Center (1)
The University of Texas MD Anderson Cancer Center Director, Red & Charline McCombs Institute for the Early Detection and Treatment of Cancer Co-Director, Center for Global Cancer Early Detection Evelyn & Sol Rubenstein Distinguished Chair for Cancer Prevention Professor, Clinical Cancer Prevention-Research Professor, Translational Molecular Pathology (1)
Vancouver Prostate Centre (1)

Tags

xref:PubMed:33472063 (4)
xref:PubMed:19778445 (1)
xref:PubMed:37978271 (1)

Previous page
1 / 540
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 540
Next page

Sort by:

Relevance

Page size

Disorder-driven non-Anderson transition in a Weyl semimetal.

Not available

S-EPMC12541400 | biostudies-literature

Stiefel MD Anderson OroPharynx cancer (MDA-OPC) cohort: a single-institution, prospective longitudinal outcomes study.

Not available

S-EPMC12645653 | biostudies-literature

Symptom recovery after thoracic surgery: Measuring patient-reported outcomes with the MD Anderson Symptom Inventory.

Not available

S-EPMC4554973 | biostudies-literature

Observation of non-Hermitian topological Anderson insulator in quantum dynamics.

Not available

S-EPMC9184487 | biostudies-literature

A polyamine-centric blood-based metabolite panel predictive of poor response to CAR T-cell therapy in large B cell lymphoma

Anti-CD19 chimeric antigen receptor (CAR) T-cell therapy for relapsed or refractory (r/r) large B-cell lymphoma (LBCL) results in durable response in only a subset of patients. MYC overexpression in LBCL tumors is associated with poor response to treatment. We tested whether a MYC-driven polyamin...

2022-10-31 | MTBLS5381 | MetaboLights

Anderson localization of electrons in single crystals: Li (x) Fe(7)Se(8).

Not available

S-EPMC4788481 | biostudies-literature

Expression data from FACS-sorted CD8+BTLA+ vs CD8+BTLA- Human Tumor-infiltrating Lymphocytes in Metastatic Melanoma

Adoptive T-cell Therapy (ACT) involves using tumor-infiltrating lymphocytes (TIL) isolated from metastatic melanoma and expanding them ex vivo prior to infusion into lympho-depleted patients. This is one of the most promising approaches to treat metastatic melanoma, with the rates of clinical respo...

ORGANISM(S): Homo sapiens

2013-01-03 | E-GEOD-43260 | biostudies-arrayexpress

Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module.

Not available

S-EPMC4095802 | biostudies-literature

Family care and predictors of the disabled elderly in China: A cross-sectional study based on the Anderson model.

Not available

S-EPMC11534204 | biostudies-literature

Animal model of Sar1b deficiency presents lipid absorption deficits similar to Anderson disease.

Not available

S-EPMC4319984 | biostudies-literature